What is the role of immunoscintigraphy in the workup of metastatic and advanced prostate cancer?

Updated: Dec 29, 2020
  • Author: Martha K Terris, MD, FACS; Chief Editor: Edward David Kim, MD, FACS  more...
  • Print


ProstaScint scanning is used to reveal extraprostatic disease (ie, localized recurrence or lymphatic spread). [8] ProstaScint scans frequently yield false-negative results, but the specificity of these studies may be improved when they are combined with CT scanning or single-photon emission CT (SPECT) scanning. [9]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!